SOLUBLE FAS/FASL LEVELS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB AND ADALIMUMAB

被引：0
|
作者：
Terenzi, R. [1 ]
Guiducci, S. [1 ]
Nacci, F. [1 ]
Romano, E. [1 ]
Manetti, M. [1 ]
Peruzzi, F. [1 ]
Bruni, C. [1 ]
Bartoli, F. [1 ]
Matucci-Cerinic, M. [1 ]
机构：
[1] Univ Florence, Dept Med, Div Rheumatol, Florence, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷
关键词：
D O I：
10.1136/annrheumdis-2012-eular.3097
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：522 / 522
页数：1
相关论文
共 50 条
  • [1] Serum Levels of Soluble Fas in Rheumatoid Arthritis Patients Treated With Infliximab
    Szmyrka-Kaczmarek, Magdalena
    Wiland, Piotr
    Szechinski, Jacek
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 17 (04): : 411 - 414
  • [2] Fas/FasL and TF/FVII levels in rheumatoid arthritis patients treated with TNF antagonists
    Guiducci, Serena
    Nacci, Francesca
    Bartoli, Francesca
    Romano, Eloisa
    Ceccarelli, Claudia
    Fiori, Ginevra
    Sacu, Oana M.
    Bongi, Susana Maddali
    Matucci-Cerinic, Marco
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 706 - 706
  • [3] The levels of serum soluble Fas in patients with rheumatoid arthritis and systemic sclerosis
    Ates, A
    Kinikli, G
    Turgay, M
    Duman, M
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 78 - 78
  • [4] Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis
    Kobak, S.
    Berdeli, A.
    REUMATISMO, 2012, 64 (06) : 374 - 379
  • [5] Infliximab failures in rheumatoid arthritis can be successfully treated with adalimumab (Humira®)
    Van der Bijl, AE
    Breedveld, FC
    Antoni, C
    Kalden, JR
    Kary, S
    Burmester, GR
    Voss, B
    Kupper, H
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 264 - 264
  • [6] The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis
    Ates, A
    Kinikli, G
    Turgay, M
    Duman, M
    CLINICAL RHEUMATOLOGY, 2004, 23 (05) : 421 - 425
  • [7] The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis
    Aşkın Ateş
    Gülay Kinikli
    Murat Turgay
    Murat Duman
    Clinical Rheumatology, 2004, 23 : 421 - 425
  • [8] Soluble Fas and Fas ligand in the joints of patients with rheumatoid arthritis and osteoarthritis
    Mrabet, D
    Hajri, R
    Hamzaoui, K
    Zakraoui, L
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 161 - 161
  • [9] Agreement in assessment of infliximab and adalimumab levels in rheumatoid arthritis: interlaboratory and interassay comparison
    Valor, L.
    Hernandez-Florez, D.
    de la Torre, I.
    Llinares, F.
    Rosas, J.
    Yaguee, J.
    Garrido, J.
    Naredo, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (05) : 617 - 623
  • [10] COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING
    Gokhale, S. B.
    Cassel, T.
    Mahon, R.
    Balkin, P. E.
    Singh, S.
    Bhattacharyya, S.
    Handin, J.
    Mendoza, C.
    VALUE IN HEALTH, 2016, 19 (07) : A535 - A535
12345